Los Angeles Capital Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-178,840
Closed -$1.22M 1202
2024
Q2
$1.22M Sell
178,840
-15,151
-8% -$103K ﹤0.01% 589
2024
Q1
$491K Buy
193,991
+32,460
+20% +$82.1K ﹤0.01% 875
2023
Q4
$388K Sell
161,531
-11,184
-6% -$26.8K ﹤0.01% 945
2023
Q3
$587K Buy
172,715
+82,996
+93% +$282K ﹤0.01% 781
2023
Q2
$659K Buy
89,719
+45,255
+102% +$333K ﹤0.01% 765
2023
Q1
$461K Buy
+44,464
New +$461K ﹤0.01% 876
2022
Q1
Sell
-8,733
Closed -$380K 1428
2021
Q4
$380K Sell
8,733
-8,892
-50% -$387K ﹤0.01% 1136
2021
Q3
$882K Buy
17,625
+8,460
+92% +$423K ﹤0.01% 805
2021
Q2
$577K Buy
9,165
+250
+3% +$15.7K ﹤0.01% 1114
2021
Q1
$828K Sell
8,915
-5,705
-39% -$530K ﹤0.01% 983
2020
Q4
$1.31M Sell
14,620
-219
-1% -$19.6K 0.01% 815
2020
Q3
$1.53M Buy
14,839
+440
+3% +$45.5K 0.01% 657
2020
Q2
$1.14M Sell
14,399
-1,785
-11% -$141K 0.01% 796
2020
Q1
$936K Hold
16,184
0.01% 728
2019
Q4
$873K Sell
16,184
-6,745
-29% -$364K ﹤0.01% 878
2019
Q3
$1.2M Sell
22,929
-200
-0.9% -$10.5K 0.01% 763
2019
Q2
$1.12M Hold
23,129
0.01% 813
2019
Q1
$1.17M Sell
23,129
-290
-1% -$14.6K 0.01% 802
2018
Q4
$1.39M Sell
23,419
-4,220
-15% -$250K 0.01% 645
2018
Q3
$1.82M Sell
27,639
-1,772
-6% -$117K 0.01% 691
2018
Q2
$1.49M Sell
29,411
-4,270
-13% -$216K 0.01% 783
2018
Q1
$1.77M Sell
33,681
-30,255
-47% -$1.59M 0.01% 669
2017
Q4
$2.97M Buy
63,936
+37,874
+145% +$1.76M 0.02% 556
2017
Q3
$1.05M Buy
26,062
+18,360
+238% +$743K 0.01% 804
2017
Q2
$261K Sell
7,702
-2,810
-27% -$95.2K ﹤0.01% 1096
2017
Q1
$305K Buy
+10,512
New +$305K ﹤0.01% 1011
2016
Q4
Sell
-6,573
Closed -$207K 1179
2016
Q3
$207K Buy
+6,573
New +$207K ﹤0.01% 1160
2016
Q2
Sell
-19,854
Closed -$722K 1246
2016
Q1
$722K Sell
19,854
-22,036
-53% -$801K 0.01% 715
2015
Q4
$1.68M Sell
41,890
-1,420
-3% -$56.8K 0.02% 545
2015
Q3
$1.23M Buy
43,310
+22,240
+106% +$634K 0.01% 641
2015
Q2
$694K Buy
+21,070
New +$694K 0.01% 851
2013
Q4
Sell
-18,565
Closed -$354K 1284
2013
Q3
$354K Buy
18,565
+370
+2% +$7.06K ﹤0.01% 1031
2013
Q2
$262K Buy
+18,195
New +$262K ﹤0.01% 1121